20+ Years of Experience
In cardiovascular physiology and clinical translation
About BLH Medical Technologies
BLH Medical Technologies is a cardiovascular AI and medical technology company focused on noninvasive hemodynamic assessment and physiological decision support for hypertension management.
BLH has developed the proprietary Hemodynaomics framework and BPmap™ platform—an AI-enabled approach to understand physiological drivers and support clinician-supervised hypertension care.
Zheng J. Ma, PhD, MBA
Founder and Chief Scientist
• PhD in Biostatistics, Yale University
• MBA, Columbia Business School
• Formerly with the U.S. FDA and Pfizer
• 20+ years of experience in clinical research, regulatory science, and digital health innovation
Peer-Reviewed Research
Yale-affiliated international publications
Randomized Clinical Evidence
Three China-based randomized trials
Proprietary Hemodynaomics IP
Science of integrating hemodynamics, vascular function, and clinical context